Indeed, FAK1 inhibition using GSK2256098 suppressed in vitro ccRCC cell line proliferation and FAK1 knockdown in ccRCC cells suppressed both in vitro and in vivo tumor growth. The gene discussed is PTK2; the disease is nonpapillary renal cell carcinoma.